CÁNCER DE MAMA
Harvard Medical School
Boston, Estados UnidosPublications en collaboration avec des chercheurs de Harvard Medical School (2)
2020
-
Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis
Breast Cancer Research and Treatment, Vol. 180, Núm. 3, pp. 597-609
2011
-
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
PLoS Biology, Vol. 9, Núm. 11